Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive Officer
Dr. Huang brings more than 30 years of biopharma experience, most recently as Chief Executive Officer and President of Flagship Pioneering start-up Cygnal Therapeutics Dunad